Brinker Capital Investments’s Takeda Pharmaceutical TAK Stock Holding History

Brinker Capital Investments’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.78M	Buy	110,838 +13,525	+14%	+$224K	0.01%	863
2026 Q1	$1.8M	Buy	97,313 +18,518	+24%	+$325K	0.02%	805
2025 Q4	$1.23M	Buy	78,795 +6,960	+10%	+$99.5K	0.01%	1132
2025 Q3	$1.05M	Buy	71,835 +15,399	+27%	+$229K	0.01%	1200
2025 Q2	$873K	Buy	56,436 +13,118	+30%	+$194K	0.01%	1257
2025 Q1	$644K	Buy	43,318 +30,320	+233%	+$425K	0.01%	1286
2024 Q4	$172K	Buy	+12,998	New	+$179K	﹤0.01%	1767

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Brinker Capital Investments's TAK Position: Q2 2026 in Review

Brinker Capital Investments increased its Takeda Pharmaceutical (TAK) stake by 14% in Q2 2026, buying an estimated $224K and bringing the position to 110,838 shares worth $1.78M. The position accounts for 0.01% of the portfolio, ranked #863.

Brinker Capital Investments first reported a position in TAK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.8M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Brinker Capital Investments held 110,838 shares of Takeda Pharmaceutical worth $1.78M as of Q2 2026.
Brinker Capital Investments bought 13,525 Takeda Pharmaceutical shares in Q2 2026, an estimated $224K.
Takeda Pharmaceutical made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #863 holding.
Brinker Capital Investments first reported a position in Takeda Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
Brinker Capital Investments's Takeda Pharmaceutical position peaked at $1.8M in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.